An 85-year-old man arrives with his daughter to discuss options for end-stage kidney disease (ESKD) management. He has stage G5/A3 chronic kidney disease due to diabetic nephropathy and hypertension. History is also significant for a 3-year history of Alzheimer disease and heart failure with a left ventricular ejection fraction of 35%. Medications are aspirin, losartan, furosemide, carvedilol, and calcium acetate. The patient is a resident of a nursing facility.

On physical examination, the patient appears comfortable but is not oriented to place or time. Temperature is 37.0 °C (98.6 °F), blood pressure is 142/70 mm Hg, pulse rate is 82/min, and respiration rate is 18/min. BMI is 21. The lungs are clear. There is trace bipedal edema. The remainder of the examination is unremarkable.

Laboratory studies are notable for a blood urea nitrogen level of 82 mg/dL (29.3 mmol/L), a serum creatinine level of 5.1 mg/dL (450.8 µmol/L), and an estimated glomerular filtration rate of 9 mL/min/1.73 m2.

Which of the following is the most appropriate recommendation for management of this patient's ESKD?